Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Fluvastatin safely and effectively improves lipid profiles in transplant recipients

Sep. 26, 1997

Potent and selective progestogens from Theramex

Sep. 26, 1997

Positive efficacy results obtained in phase II trial of ALX1-11; phase III trials will begin soon

Sep. 25, 1997

Crinone approved for marketing in Germany

Sep. 25, 1997

Osteoporosis indication for tiludronate dropped

Sep. 25, 1997

Spotlight on bisphosphonates in osteoporosis

Sep. 25, 1997

Novo Nordisk presents potassium channel openers/blockers

Sep. 25, 1997

Study results of Crinone as ART treatment presented

Sep. 24, 1997

Acute vasodilating effects of KDI-792 in diabetics

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...